Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1959 2
1960 3
1962 2
1963 4
1964 4
1965 10
1966 9
1967 6
1968 13
1969 7
1970 8
1971 13
1972 11
1973 10
1974 22
1975 9
1976 14
1977 18
1978 29
1979 31
1980 47
1981 41
1982 50
1983 48
1984 46
1985 52
1986 56
1987 62
1988 60
1989 81
1990 59
1991 79
1992 102
1993 62
1994 72
1995 90
1996 94
1997 89
1998 107
1999 99
2000 125
2001 111
2002 107
2003 110
2004 138
2005 162
2006 176
2007 172
2008 197
2009 207
2010 209
2011 211
2012 244
2013 246
2014 246
2015 234
2016 257
2017 232
2018 256
2019 298
2020 290
2021 257
2022 218
2023 198
2024 106

Text availability

Article attribute

Article type

Publication date

Search Results

6,031 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of Mesothelioma.
Fels Elliott DR, Jones KD. Fels Elliott DR, et al. Surg Pathol Clin. 2020 Mar;13(1):73-89. doi: 10.1016/j.path.2019.10.001. Epub 2019 Dec 3. Surg Pathol Clin. 2020. PMID: 32005436 Review.
Mesothelioma is a rare neoplasm that arises from mesothelial cells lining body cavities including the pleura, pericardium, peritoneum, and tunica vaginalis. Most malignant mesotheliomas occur in the chest and are frequently associated with a history of asbestos exposure. T …
Mesothelioma is a rare neoplasm that arises from mesothelial cells lining body cavities including the pleura, pericardium, peritoneum …
Peritoneal Mesothelioma-An Update.
Malpica A. Malpica A. Adv Anat Pathol. 2023 Jul 1;30(4):262-274. doi: 10.1097/PAP.0000000000000387. Epub 2022 Dec 12. Adv Anat Pathol. 2023. PMID: 36729766
A remarkable amount of new information has been generated on peritoneal mesothelioma (PeM), ranging from nomenclature changes, including the removal of "malignant" when referring to this neoplasm and the use of the term "tumor" rather than "mesothelioma" to designat …
A remarkable amount of new information has been generated on peritoneal mesothelioma (PeM), ranging from nomenclature changes, includ …
Malignant Mesothelioma Diagnosis.
Arif Q, Husain AN. Arif Q, et al. Arch Pathol Lab Med. 2015 Aug;139(8):978-80. doi: 10.5858/arpa.2013-0381-RA. Arch Pathol Lab Med. 2015. PMID: 26230591 Free article. Review.
CONTEXT: Malignant mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors including carcinomas and sarcomas. ...Recent studies have shown that the high-grade subgroup of deciduoid mesothelioma with pleomorp …
CONTEXT: Malignant mesothelioma is a relatively rare pleural tumor that may mimic benign mesothelial lesions and various other tumors …
Biomarkers in mesothelioma.
Arnold DT, Maskell NA. Arnold DT, et al. Ann Clin Biochem. 2018 Jan;55(1):49-58. doi: 10.1177/0004563217741145. Epub 2017 Nov 13. Ann Clin Biochem. 2018. PMID: 29058958 Review.
Mesothelioma is an aggressive cancer of pleural and peritoneal cells that is difficult to diagnose and monitor. ...Although many DNA and mRNA biomarkers show promise in the diagnosis or screening of mesothelioma, none have been prospectively evaluated for use in cli …
Mesothelioma is an aggressive cancer of pleural and peritoneal cells that is difficult to diagnose and monitor. ...Although many DNA …
Updates on grading mesothelioma.
Schulte JJ, Husain AN. Schulte JJ, et al. Histopathology. 2024 Jan;84(1):153-162. doi: 10.1111/his.15065. Epub 2023 Oct 23. Histopathology. 2024. PMID: 37872123 Review.
Mesothelioma is a rare disease with an historically poor prognosis. Over the past decade, a grading system has been developed that is a powerful prognostic tool in epithelioid mesothelioma. Grading of epithelioid mesothelioma is now required or strongly recom …
Mesothelioma is a rare disease with an historically poor prognosis. Over the past decade, a grading system has been developed that is …
Biomarkers for mesothelioma.
Scherpereel A, Lee YC. Scherpereel A, et al. Curr Opin Pulm Med. 2007 Jul;13(4):339-443. doi: 10.1097/MCP.0b013e32812144bb. Curr Opin Pulm Med. 2007. PMID: 17534183 Review.
PURPOSE OF REVIEW: Mesothelioma is an incurable cancer and its global incidence continues to increase. ...The role of SMRP in predicting mesothelioma development in subjects exposed to asbestos has raised interest. ...
PURPOSE OF REVIEW: Mesothelioma is an incurable cancer and its global incidence continues to increase. ...The role of SMRP in predict …
The cytologic diagnosis of mesothelioma: are we there yet?
Michael CW. Michael CW. J Am Soc Cytopathol. 2023 Mar-Apr;12(2):89-104. doi: 10.1016/j.jasc.2022.12.001. Epub 2022 Dec 26. J Am Soc Cytopathol. 2023. PMID: 36702736 Review.
INTRODUCTION: Mesothelioma is a rare but highly aggressive malignancy with poor prognosis that frequently present with recurrent effusions. ...MATERIALS AND METHODS: This review examines the cytological diagnosis of mesothelioma in the context of its historical and …
INTRODUCTION: Mesothelioma is a rare but highly aggressive malignancy with poor prognosis that frequently present with recurrent effu …
Pleural Mesothelioma: Current Practice and Approach.
Lenskaya V, Moran CA. Lenskaya V, et al. Adv Anat Pathol. 2023 Jul 1;30(4):243-252. doi: 10.1097/PAP.0000000000000390. Epub 2022 Dec 19. Adv Anat Pathol. 2023. PMID: 36689647
In the era of immunohistochemistry, a combination of carcinomatous epitopes and positive mesothelioma markers has become paramount in the diagnosis of mesothelioma, and more recently the use of molecular techniques has become another ancillary tool in supporting suc …
In the era of immunohistochemistry, a combination of carcinomatous epitopes and positive mesothelioma markers has become paramount in …
Revisiting localized malignant mesothelioma.
Mann S, Khawar S, Moran C, Kalhor N. Mann S, et al. Ann Diagn Pathol. 2019 Apr;39:74-77. doi: 10.1016/j.anndiagpath.2019.02.014. Epub 2019 Feb 19. Ann Diagn Pathol. 2019. PMID: 30798074 Review.
Malignant Mesothelioma is an uncommon tumor that usually presents with diffuse pleural involvement and carries a dismal prognosis. ...We found four such cases in our database. Three patients had localized epithelioid malignant mesothelioma and one had localized sarc …
Malignant Mesothelioma is an uncommon tumor that usually presents with diffuse pleural involvement and carries a dismal prognosis. .. …
Signet ring cell mesothelioma; A diagnostic challenge.
Wang H, Herath C. Wang H, et al. Pathol Res Pract. 2019 Jul;215(7):152462. doi: 10.1016/j.prp.2019.152462. Epub 2019 May 22. Pathol Res Pract. 2019. PMID: 31146976 Review.
Signet ring cell mesothelioma is a rare variant of epithelioid mesothelioma with limited cases published. ...Electron microscopy and genetic testing can be very helpful in distinguishing signet ring cell mesothelioma from its mimickers....
Signet ring cell mesothelioma is a rare variant of epithelioid mesothelioma with limited cases published. ...Electron microsco …
6,031 results